Article: Brain and optic chiasmal herniations into sella after cabergoline therapy of giant prolactinoma

Optic chiasmal herniation following dopamine agonist therapy is a rare complication in patients with giant prolactinomas. But there are a few case reports of brain and chiasmal herniation following medical therapy in such cases. We report a young man who developed secondary visual loss and seizures after 6 months of medical treatment with cabergoline for giant prolactinoma. Magnetic resonance imaging of hypothalamic pituitary region revealed optic chiasmal and frontal lobe herniation into sella. There was marginal improvement in his vision after cabergoline dose reduction. The present case report highlights frontal lobe herniation in conjunction with optic chiasmal herniation as a very rare complication of medical therapy of giant prolactinoma. Different treatment options of this condition are being discussed.

Citing Articles

Giant Clinically Non-Functioning Pituitary Adenoma Presenting as New Onset Generalized Tonic‒Clonic Seizures: A Case Report.

Weerasekara P, Chandraratne N, Perera S Int Med Case Rep J. 2024; 17:527-533.

PMID: 38799383 PMC: 11128223. DOI: 10.2147/IMCRJ.S465564.

TEMPORAL LOBE HERNIATION AND CHIASMOPATHY DURING DOPAMINE AGONIST THERAPY FOR PROLACTINOMA.

Giraldi E, Saindane A, Pradilla G, Biousse V, Ioachimescu A Acta Endocrinol (Buchar). 2024; 19(3):339-344.

PMID: 38356985 PMC: 10863970. DOI: 10.4183/aeb.2023.339.

Empty Sella Syndrome as a Window Into the Neuroprotective Effects of Prolactin.

Paul D, Strawderman E, Rodriguez A, Hoang R, Schneider C, Haber S Front Med (Lausanne). 2021; 8:680602.

PMID: 34307410 PMC: 8295462. DOI: 10.3389/fmed.2021.680602.

Case Report: Suprasellar Pituitary Adenoma Presenting With Temporal Lobe Seizures.

Hong C, Gorrepati R, Kundishora A, Elsamadicy A, Peter P, Damisah E Front Surg. 2020; 7:598138.

PMID: 33335912 PMC: 7736041. DOI: 10.3389/fsurg.2020.598138.

Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations.

Graillon T, Passeri T, Boucekine M, Meyer M, Abritti R, Bernat A Pituitary. 2020; 24(2):292-301.

PMID: 33136230 DOI: 10.1007/s11102-020-01104-5.

References

1.

Bangash M, Clarke D, Holness R . Brain & chiasmal herniations into sella after medical treatment of prolactinoma. Can J Neurol Sci. 2006; 33(2):240-2. DOI: 10.1017/s0317167100005060. View

2.

Chuman H, Cornblath W, Trobe J, Gebarski S . Delayed visual loss following pergolide treatment of a prolactinoma. J Neuroophthalmol. 2002; 22(2):102-6. DOI: 10.1097/00041327-200206000-00008. View

3.

Keyaki A, Makita Y, Nabeshima S, Motomochi M, Itagaki T, Tei T . [Secondary empty sella syndrome: report of three cases and review of the literature]. No Shinkei Geka. 1982; 10(11):1189-94. View

4.

Raverot G, Jacob M, Jouanneau E, Delemer B, Vighetto A, Pugeat M . Secondary deterioration of visual field during cabergoline treatment for macroprolactinoma. Clin Endocrinol (Oxf). 2008; 70(4):588-92. DOI: 10.1111/j.1365-2265.2008.03364.x. View

5.

Kubo S, Hasegawa H, Inui T, Tominaga S, Yoshimine T . Endonasal endoscopic transsphenoidal chiasmapexy with silicone plates for empty sella syndrome: technical note. Neurol Med Chir (Tokyo). 2005; 45(8):428-32. DOI: 10.2176/nmc.45.428. View

Brain and Optic Chiasmal Herniations into Sella After Cabergoline Therapy of Giant Prolactinoma